Sézary syndrome: Report of a rare case with perioral manifestation and review of the literature

Oral Oncol. 2022 Nov:134:106134. doi: 10.1016/j.oraloncology.2022.106134. Epub 2022 Sep 29.

Abstract

This report aimed to describe a rare case of Sézary syndrome (SS) diagnosed in an Oral Medicine service. A 54-year-old female presented a generalized pruritus and erythema of the skin of 2 years in duration, which had been treated with antihistamines, corticosteroids, and hydrating creams, without resolution. Extra-oral examination showed a painful lymphadenopathy on the right supraclavicular region. Ultrasound-guided fine-needle aspirationbiopsy did not detect any abnormalities. The patient's skin was remarkably dry and thickened, with erythroderma, fissures, and ulcerations. The perioral region exhibited extreme peeling and angular cheilitis. Immunophenotyping of peripheral blood revealed proliferation of undifferentiated T-cells and a massive proportion of TCD4+ cells relative to TCD8+ cells. PET/CT examination demonstrated multiple lymphadenopathies, and bone marrow biopsy was negative for neoplastic cell infiltration. A diagnosis of SS was established, and the patient is currently being treated with UVB phototherapy, methotrexate, doxepin, and folic acid, with mostly complete regression of signs and symptoms.

Keywords: Cutaneous T-cell lymphoma; Non-Hodgkin’s lymphoma; Sézary syndrome.

Publication types

  • Case Reports
  • Letter
  • Review

MeSH terms

  • Adrenal Cortex Hormones
  • Doxepin
  • Female
  • Folic Acid
  • Humans
  • Lymphadenopathy*
  • Methotrexate
  • Middle Aged
  • Positron Emission Tomography Computed Tomography
  • Sezary Syndrome* / diagnosis
  • Sezary Syndrome* / pathology
  • Sezary Syndrome* / therapy
  • Skin Neoplasms* / diagnosis
  • Skin Neoplasms* / pathology
  • Skin Neoplasms* / therapy

Substances

  • Adrenal Cortex Hormones
  • Doxepin
  • Folic Acid
  • Methotrexate